Giuseppe Tarantini - Department of Hematology, ASL BT

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 40 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparison of Isatuximab-Pomalidomide-dexamethasone Versus Elotuzumab-Pomalidomidedexamethasone in Relapsed/refractory Multiple Myeloma Patients: a Target Trial Emulation Using Real-World Data

Enrica Antonia Martino,Annalisa Pitino,Massimo Offidani,Roberta Della Pepa,Alessandro Gozzetti,Velia Bongarzoni, Antonio Maroccia,Valeria Amico,Paola Stefanoni,Elena Zamagni, Sofia Terlizzi,Daniele Derudas,Salvatore Palmieri,Rosario Bianco,Concetta Conticello,Marino Brunori,Angela Rago, Flavia Lotti,Raffaele Fontana,Nicola Sgherza,Elena Rossi,Anna Maria Cafro,Massimiliano Arangio Febbo,Angela Maria Quinto,Claudio Cerchione,Gloria Margiotta Casaluci,Annalisa Citro,Catello Califano,Renato Zambello,Silvia Mangiacavalli,Carmine Liberatore,Gabriele Buda,Claudio De Magistris,Angela Amendola,Ernesto Vigna,Antonella Bruzzese,Emiliano Barbieri,Micol Quaresima, Daniela Roccotelli,Francesca Farina,Jacopo Micozzi,Iolanda Donatella Vincelli,Giuseppe Tarantini,Elisabetta Antonioli,Sara Aquino,Alessandro Maggi,Alessandra Lombardo,Giuseppe Bertuglia,Anna Furlan,Anna Mele,Ombretta Annibali,Emilia Cotzia,Pietro Benvenuti,Lorenzo De Paoli,Gregorio Barilà,Sonia Morè,Valerio De Stefano,Francesco Di Raimondo,Maria Teresa Petrucci,Niccolò Bolli,Pellegrino Musto,Antonino Neri,Fortunato Morabito,Giovanni Tripepi,Massimo Gentile

Haematologica (2025)

引用0浏览0WOS引用

Correction: Sgherza Et Al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (isakd) in Multiple Myeloma Patients at the First Relapse after Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595

Nicola Sgherza, Olga Battisti,Paola Curci,Concetta Conticello, Salvatore Palmieri,Daniele Derudas,Candida Germano,Enrica Antonia Martino,Giuseppe Mele, Roberta Della Pepa, Francesca Fazio,Anna Mele,Bernardo Rossini,Giulia Palazzo, Daniela Roccotelli, Simona Rasola,Maria Teresa Petrucci,Domenico Pastore,Giuseppe Tarantini,Fabrizio Pane,Massimo Gentile,Francesco Di Raimondo, Emanuela Resta,Pellegrino Musto

Pharmaceuticals (Basel, Switzerland)no. 6 (2025)

引用0浏览0WOS引用

Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated with Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients

Fortunato Morabito,Enrica Antonia Martino,Monica Galli,Massimo Offidani,Renato Zambello,Sara Bringhen,Nicola Giuliani,Catello Califano, Marino Brunori,Alfredo Gagliardi,Nicola Sgherza,Angela Maria Quinto, Gregorio Barilà,Angelo Belotti,Claudio Cerchione, Gloria Margiotta Casaluci,Raffaele Fontana,Velia Bongarzoni,Giuseppe Tarantini,Daniele Derudas,Francesca Patriarca,Alessandro Gozzetti, Adelina Sementa,Elisabetta Antonioli,Angela Rago, Flavia Lotti, Claudio De Magistris,Maria Teresa Petrucci,Loredana Pettine,Niccolò Bolli,Concetta Conticello,Elena Zamagni, Salvatore Palmieri,Maurizio Musso,Anna Mele, Roberta Della Pepa,Ernesto Vigna,Antonella Bruzzese, Francesca Fazio,Roberto Mina,Laura Paris, Iolanda Donatella Vincelli, Giuliana Farina,Clotilde Cangialosi,Katia Mancuso,Antonietta Pia Falcone,Giuseppe Mele, Antonello Sica, Sonia Morè,Giovanni Reddiconto,Giovanni Tripepi,Graziella D'Arrigo, Emiliano Barbieri,Micol Quaresima, Claudio Salvatore Cartia, Sara Pezzatti,Magda Marcatti,Francesca Farina,Anna Cafro, Michele Palumbo, Valeria Masoni,Virginia Valeria Ferretti,Francesco Di Raimondo,Pellegrino Musto,Antonino Neri,Silvia Mangiacavalli,Massimo Gentile

European journal of haematologyno. 1 (2025): 16-28

引用0浏览0WOS引用

Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (isakd) in Multiple Myeloma Patients at the First Relapse after Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life Aeneid Study

Pharmaceuticals (Basel, Switzerland)no. 4 (2025)

引用0浏览0WOS引用

A Rare Case of IgDλ/λ Free Multiple Myeloma As a Virtuous Example of Collaboration Between Clinical Activity and Laboratory Medicine

Mauro Sasso, Candida Rosaria Germano, Vanda Staffella, Luigi Ceci,Giuseppe Tarantini

crossref（2024）

引用0浏览0引用

Elotuzumab Plus Pomalidomide and Dexamethasone in Relapsed/refractory Multiple Myeloma: Extended Follow-Up of a Multicenter, Retrospective Real-World Experience with 321 Cases Outside of Controlled Clinical Trials

Enrica Antonia Martino,Salvatore Palmieri,Monica Galli,Daniele Derudas,Roberto Mina,Roberta Della Pepa,Renato Zambello,Ernesto Vigna,Antonella Bruzzese,Silvia Mangiacavalli,Elena Zamagni,Catello Califano,Maurizio Musso,Concetta Conticello,Claudio Cerchione,Giuseppe Mele,Nicola Di Renzo,Massimo Offidani,Giuseppe Tarantini,Gloria Margiotta Casaluci,Angela Rago,Roberto Ria,Giuseppina Uccello,Gregorio Barila,Gaetano Palumbo,Loredana Pettine,Iolanda Donatella Vincelli,Marino Brunori,Fabrizio Accardi,Valeria Amico,Angela Amendola,Raffaele Fontana,Velia Bongarzoni,Bernardo Rossini,Emilia Cotzia,Alessandro Gozzetti,Rita Rizzi,Nicola Sgherza,Giovanni Reddiconto,Antonio Maroccia,Luca Franceschini,Giuseppe Bertuglia,Davide Nappi,Emiliano Barbieri,Barbara Gamberi,Maria Teresa Petrucci,Francesco Di Raimondo,Antonino Neri,Fortunato Morabito,Pellegrino Musto,Massimo Gentile

HEMATOLOGICAL ONCOLOGYno. 4 (2024)

引用3浏览0WOS引用

REAL-WORLD EFFECTIVENES OF VENETOCLAX COMBINED WITH IPOMETILATING-AGENTS AS A BRIDGE TO ALLOGENEIC TRANSPLANTATION IN ACUTE MIELOID LEUKEMIA: RETROSPECTIVE AND MULTICENTRIC STUDY OF APULIAN HEMATOLOGICAL NETWORK "REP05"

Vincenzo Federico,Rosella Matera,Domenico Pastore,Giuseppe Tarantini,Lorella Melillo,Angelo Michele Carella,Attilio Guarini,Caterina Buquicchio,Lucia Ciuffreda,Mariachiara Abbenante,Paola Carluccio,Crescenza Pasciolla, Mariapaolo Fina,Alessandro Spina, Marina Urbano,Daniela Carlino, Mariangela Lecciso,Michelina Dargenio,Davide Seripa,Pellegrino Musto,Giorgina Specchia,Nicola Di Renzo

BONE MARROW TRANSPLANTATION (2024): 541-542

引用0浏览0引用

Elotuzumab Plus Pomalidomide and Dexamethasone in Relapsed/refractory Multiple Myeloma: a Multicenter, Retrospective, Real-World Experience with 200 Cases Outside of Controlled Clinical Trials

Haematologica（2024）

引用9浏览0WOS引用

Daratumumab-based Regimens for Patients with Multiple Myeloma Plus Extramedullary Plasmacytomas or Paraskeletal Plasmacytomas: Initial Follow-Up of an Italian Multicenter Observational Clinical Experience

Giuseppe Mele,Daniele Derudas,Concetta Conticello,Gregorio Barilà,Massimo Gentile,Stefano Rocco,Salvatore Palmieri,Giulia Palazzo,Candida Germano,Giovanni Reddiconto,Nicola Sgherza,Danilo De Novellis, Carlotta Galeone, Sara Agavni’ Castiglioni, Luca Deiana,Anna Pascarella,Enrica Antonia Martino, Ilaria Foggetti, Ilenia Blasi,Alessandro Spina,Nicola Di Renzo,Alessandro Maggi,Giuseppe Tarantini,Francesco Di Raimondo,Giorgina Specchia,Pellegrino Musto,Domenico Pastore

ANNALS OF HEMATOLOGYno. 8 (2024): 3061-3069

引用0浏览0WOS引用

CML Patients Who Fail to Achieve ≤ 1% BCR::ABL1 at 12 Months or < 0.1% BCR::ABL1 at 24 Months (major Molecular Response, MMR) Show Significantly Inferior Survival, but Not Due to CML-Related Deaths: Data from an Italian Real-Life Observational Study

BLOOD (2024): 3155-3157

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn